Orphan kidney diseases.
نویسنده
چکیده
Rare kidney diseases are a unique subset of renal disorders that are often termed 'orphan' as a result of a multitude of reasons: the small number of patients with the consequent lack of well-defined natural history and course of many of these diseases, limited awareness among the medical community, and finally the significant cost of developing novel therapeutics which makes many of these diseases unattractive targets for the pharmaceutical industry. Nevertheless, in the last decade the study and clinical management of rare kidney disease patients has been the focus of many investigative efforts. In recent years we have witnessed an enormous expansion in our knowledge of the genetic nature of a number of rare kidney diseases. Moreover, the investigation of the role of genetic disruption aiming at elucidating the pathogenesis of different and complex renal diseases has helped not only in understanding the disease states, but has also given us fundamental insights into a number of kidney developmental and physiological functions. This article will give an overview of orphan renal diseases with particular emphasis on monogenic kidney diseases. It will also focus on the classification of these diseases while highlighting a prominent example in each category.
منابع مشابه
Orphan drug incentives in the pharmacogenomic context: policy responses in the USA and Canada
INTRODUCTION The US Orphan Drug Act1 is a policy response to diseases that have been orphaned under ordinary market conditions, and thus remain unmet medical needs.They create special, streamlined regulatory pathways and incentives such as grant funding, tax credits, and market exclusivity in order to encourage drug researchers and firms to develop interventions that address these unmet medical...
متن کاملA cost-effectiveness analysis of the orphan drug cysteamine in the treatment of infantile cystinosis.
OBJECTIVE Cysteamine is a recently licensed orphan drug used to treat the inherited metabolic disease cystinosis. The drug delays the onset of renal failure in cystinotic patients and may provide many other significant health benefits. This study examined the cost-effectiveness of the administration of cysteamine to cystinotic patients prior to end-stage renal disease (ESRD). METHOD Decision-...
متن کاملThe ABCC6 Transporter as a Paradigm for Networking from an Orphan Disease to Complex Disorders
The knowledge on the genetic etiology of complex disorders largely results from the study of rare monogenic disorders. Often these common and rare diseases show phenotypic overlap, though monogenic diseases generally have a more extreme symptomatology. ABCC6, the gene responsible for pseudoxanthoma elasticum, an autosomal recessive ectopic mineralization disorder, can be considered a paradigm g...
متن کاملComparison of urinary tract infection after kidney transplantation between adult and children
Background: Urinary tract infection (UTI) is an important complication after kidney transplantation (KT). UTI may cause kidney damage and dysfunction especially in children. Therefore, the aim of this study was to evaluate the risk of UTI after KT in adult and children and compare of them. Methods: This study was done in Shaheed Beheshti Hospital (Babol Medical University). All patients, aft...
متن کاملENPP1-Fc prevents mortality and vascular calcifications in rodent model of generalized arterial calcification of infancy
Diseases of ectopic calcification of the vascular wall range from lethal orphan diseases such as generalized arterial calcification of infancy (GACI), to common diseases such as hardening of the arteries associated with aging and calciphylaxis of chronic kidney disease (CKD). GACI is a lethal orphan disease in which infants calcify the internal elastic lamina of their medium and large arteries ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Nephron. Clinical practice
دوره 120 4 شماره
صفحات -
تاریخ انتشار 2012